AIMCA
TEVA icon

Alberta Investment Management Corp (AIMCo)’s Teva Pharmaceuticals TEVA Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-91,100
Closed -$1.53M – 643
2025
Q2 		$1.53M Sell
91,100
-28,000
-24% -$452K 0.01% 391
2025
Q1 		$1.83M Hold
119,100
– – 0.01% 477
2024
Q4 		$2.62M Hold
119,100
– – 0.02% 418
2024
Q3 		$2.15M Hold
119,100
– – 0.02% 413
2024
Q2 		$1.94M Hold
119,100
– – 0.02% 377
2024
Q1 		$1.68M Hold
119,100
– – 0.02% 483
2023
Q4 		$1.24M Hold
119,100
– – 0.01% 584
2023
Q3 		$1.21M Hold
119,100
– – 0.01% 582
2023
Q2 		$897K Hold
119,100
– – 0.01% 769
2023
Q1 		$1.05M Sell
119,100
-609,300
-84% -$6.02M 0.01% 739
2022
Q4 		$6.64M Buy
728,400
+129,300
+22% +$1.13M 0.06% 357
2022
Q3 		$4.83M Buy
+599,100
New +$5.3M 0.04% 485
2021
Q1 		– Sell
-1,475,000
Closed -$14.2M – 907
2020
Q4 		$14.2M Buy
1,475,000
+184,500
+14% +$1.77M 0.13% 186
2020
Q3 		$11.6M Buy
1,290,500
+193,300
+18% +$2.04M 0.13% 192
2020
Q2 		$13.5M Sell
1,097,200
-680,500
-38% -$7.7M 0.16% 149
2020
Q1 		$16M Buy
+1,777,700
New +$18.2M 0.28% 80
2019
Q2 		– Sell
-800,700
Closed -$12.6M – 1004
2019
Q1 		$12.6M Sell
800,700
-142,800
-15% -$2.52M 0.12% 171
2018
Q4 		$14.5M Buy
943,500
+470,700
+100% +$9.65M 0.16% 150
2018
Q3 		$10.2M Buy
+472,800
New +$11M 0.09% 228
2015
Q3 		– Sell
-20,000
Closed -$1.18M – 526
2015
Q2 		$1.18M Buy
+20,000
New +$1.23M 0.01% 458

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s TEVA Position: Q3 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 91,100 shares — an estimated $1.53M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in TEVA in Q2 2015 and held it in 20 quarters. The position peaked at $16M in Q1 2020. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 91,100 Teva Pharmaceuticals shares in Q3 2025, an estimated $1.53M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 20 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Teva Pharmaceuticals position peaked at $16M in Q1 2020.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2025, filed 7 Nov 2025.